Please provide your email address to receive an email when new articles are posted on . “Contrary to the initial intentions of the multiplex assay, our study demonstrates that the inherent advantages ...
Got a stuffy nose and a cough? If you go to an urgent care or ER, chances are that you may be able find out exactly what type of germ is making you sick, thanks to newer tests that don’t look for just ...
Marlborough, Massachusetts-based Hologic already offers molecular diagnostic tests. But diagnostics companies have been looking to add multiplex offerings—the capability to identify multiple pathogens ...
Company Integrates Spectrum Solutions ™ SDNA-1000 Saliva Collection System for Advanced, Simultaneous Multi-Viral Detection of Infections and Viral Mutations GARDEN CITY, NY, Feb. 09, 2021 (GLOBE ...
Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer Although predictive multiplex somatic ...
DENVER, Jan. 15, 2026 /PRNewswire/ -- QuantiPath, a molecular diagnostics company advancing pathogen detection and food safety innovation, today announced a significant expansion of its molecular ...
LONDON--(BUSINESS WIRE)--Medical and consumer genetics testing innovator and Imperial College London spin-out, DnaNudge, today announces that it has received approval from Ghana’s Food and Drugs ...
The diagnostics advisory committee reviewed the evidence available on the clinical and cost effectiveness of using multiplex allergen testing, in combination with standard clinical assessment, to help ...
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus. In this half-day virtual summit, a series of presentations ...
GARDEN CITY, NY, Feb. 09, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, has begun new saliva-based, viral RT-PCR multiplex-testing ...
Show More Stacy W. Gray, Angel Cronin, Barrett J. Rollins, and Jane C. Weeks, Dana-Farber Cancer Institute; Stacy W. Gray, Barrett J. Rollins, and Jane C. Weeks, Harvard Medical School and Brigham and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results